Literature DB >> 6252480

Opioid receptors in the caudate nucleus can mediate EMG-recorded rigidity in rats.

U Havemann, M Winkler, K Kuschinsky.   

Abstract

Systemic administrations of opioids are known to induce "catatonia" or "lead pipe rigidity" in rats. The relevance of the caudate nucleus in inducing rigidity was tested. For this purpose, several opioids (or saline) were injected into the head of the caudate nucleus ("intrastriatal" injection) through an implanted cannula, and the electromyographical activity (EMG) was recorded in the gastrocnemius-soleus muscle (GS). Morphine (7.5-3.0 microgram), injected unilaterally, induced a continuous EMG activity in the ipsilateral GS muscle. This effect could be antagonized by systemic administration of naloxone (1 or 2 mg/kg i.p.). D-ala2-met5-enkephalinamide (3 microgram) and levorphanol (22.5 microgram) induced an EMG activity, too, whereas an equimolar dose of dextrorphan was ineffective, indicating that this effect was stereospecific and mediated via opioid receptors in the caudate nucleus. The EMG activity observed after systemic morphine administration (15 mg/kg i.p.) was antagonized by intrastriatal injection of naloxone (5 microgram). From our results, it can be concluded that the striatum--at least the head of the caudate nucleus--plays an important role in mediating the rigidity observed after systemic administration of morphine and other opioids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252480     DOI: 10.1007/bf00498570

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Indirect activation of the DA system as a possible mechanism for the stimulatory effects of narcotic analgesics.

Authors:  G Di Chiara; L Vargiu; M L Porceddu; R Longoni; A Mulas; G L Gessa
Journal:  Adv Biochem Psychopharmacol       Date:  1977

2.  Opiate receptor agonists as modulators of gamma-aminobutyric acid turnover in the nucleus caudatus, globus pallidus and substantia nigra of the rat.

Authors:  F Moroni; D L Cheney; E Peralta; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

3.  Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness.

Authors:  F Bloom; D Segal; N Ling; R Guillemin
Journal:  Science       Date:  1976-11-05       Impact factor: 47.728

4.  Synaptic localization of opiate receptors in rat striatum.

Authors:  A Carenzi; V Frigeni; D Della Bella
Journal:  Adv Biochem Psychopharmacol       Date:  1978

Review 5.  Endorphins and endorphin receptors in striatum: relationships with dopaminergic neurons.

Authors:  J C Schwartz; H Pollard; C Llorens; B Malfroy; C Gros; P Pradelles; F Dray
Journal:  Adv Biochem Psychopharmacol       Date:  1978

6.  Radioimmunoassay of enkephalins: levels of methionine- and leucine-enkephalin in morphine-dependent and kainic acid-lesioned rat brains.

Authors:  S R Childers; R Schwarcz; J T Coyle; S H Snyder
Journal:  Adv Biochem Psychopharmacol       Date:  1978

7.  Morphine-induced muscular rigidity in rats.

Authors:  P Wand; K Kuschinsky; K H Sontag
Journal:  Eur J Pharmacol       Date:  1973-11       Impact factor: 4.432

8.  Morphine catalepsy in the rat: relation to striatal dopamine metabolism.

Authors:  K Kuschinsky; O Hornykiewicz
Journal:  Eur J Pharmacol       Date:  1972-07       Impact factor: 4.432

9.  On the regulation of gamma-aminobutyric acid neurons in caudatus, pallidus and nigra: effects of opioids and dopamine agonists.

Authors:  F Moroni; E Peralta; D L Cheney; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1979-02       Impact factor: 4.030

10.  Naloxone reversal of morphine catationia: role of caudate and periaqueductal gray.

Authors:  R E Wilcox; R A Levitt
Journal:  Pharmacol Biochem Behav       Date:  1978-10       Impact factor: 3.533

View more
  9 in total

1.  Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats.

Authors:  M Winkler; U Havemann; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

2.  Effects of striatal lesions with kainic acid on morphine-induced "catatonia" and increase of striatal dopamine turnover.

Authors:  U Havemann; M Winkler; E Genç; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

3.  Antiparkinsonian effect of flupirtine in monoamine-depleted rats.

Authors:  M Schwarz; M Nolden-Koch; J Purr; G Pergande; F Block
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function.

Authors:  Mariana Spetea; Catalina R Bohotin; Muhammad F Asim; Kurt Stübegger; Helmut Schmidhammer
Journal:  Eur J Pharm Sci       Date:  2010-06-18       Impact factor: 4.384

5.  Morphine-induced hyperactivity in rats--a rebound effect?

Authors:  B Magnus-Ellenbroek; U Havemann-Reinecke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

6.  Chlorpromazine hyperalgesia antagonizes clonidine analgesia, but enhances morphine analgesia in rats tested in a hot-water tail-flick paradigm.

Authors:  R M Gleeson; D M Atrens
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Further characterization of opioid receptors in the striatum mediating muscular rigidity in rats.

Authors:  U Havemann; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

8.  The nucleus accumbens and forelimb muscular rigidity in rats.

Authors:  B A Ellenbroek; J Van den Hoven; A R Cools
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

9.  Changes in limb tone produced by regional injections of opiates into rat brain.

Authors:  P Slater; D A Starkie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.